Drug Shortage Report for PROTAMINE SULFATE INJECTION USP
Report ID | 138125 |
Drug Identification Number | 02231674 |
Brand name | PROTAMINE SULFATE INJECTION USP |
Common or Proper name | PROTAMINE SULFATE INJECTION USP |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | PROTAMINE SULFATE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 25ML 1LIVI CA |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-04-23 |
Estimated end date | 2022-08-26 |
Actual end date | 2022-08-18 |
Shortage status | Resolved |
Updated date | 2022-08-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-04-27 | English | Compare |
v2 | 2021-04-27 | French | Compare |
v3 | 2021-05-03 | English | Compare |
v4 | 2021-05-03 | French | Compare |
v5 | 2021-06-21 | English | Compare |
v6 | 2021-06-21 | French | Compare |
v7 | 2022-01-26 | English | Compare |
v8 | 2022-01-26 | French | Compare |
v9 | 2022-03-03 | English | Compare |
v10 | 2022-03-03 | French | Compare |
v11 | 2022-04-05 | English | Compare |
v12 | 2022-04-05 | French | Compare |
v13 | 2022-05-10 | English | Compare |
v14 | 2022-05-10 | English | Compare |
v15 | 2022-05-10 | French | Compare |
v16 | 2022-06-17 | English | Compare |
v17 | 2022-06-17 | French | Compare |
v18 | 2022-07-06 | English | Compare |
v19 | 2022-07-06 | French | Compare |
v20 | 2022-08-03 | English | Compare |